GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Market Cap

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Market Cap : ¥4,250 Mil (As of Apr. 15, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hunan Fangsheng Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥12.02. Hunan Fangsheng Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 439 Mil. Therefore, Hunan Fangsheng Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥5,278 Mil.

Hunan Fangsheng Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥4,946 Mil) to Jun. 2024 (¥4,515 Mil) but then increased from Jun. 2024 (¥4,515 Mil) to Sep. 2024 (¥5,278 Mil).

Hunan Fangsheng Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥2,920 Mil) to Dec. 2022 (¥3,521 Mil) and increased from Dec. 2022 (¥3,521 Mil) to Dec. 2023 (¥4,819 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hunan Fangsheng Pharmaceutical Co's Enterprise Value for Today is ¥5,003 Mil.


Hunan Fangsheng Pharmaceutical Co Market Cap Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Market Cap Chart

Hunan Fangsheng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,605.99 2,572.29 2,920.12 3,521.21 4,819.48

Hunan Fangsheng Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,856.50 4,819.48 4,945.69 4,514.56 5,278.27

Competitive Comparison of Hunan Fangsheng Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Fangsheng Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Fangsheng Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Fangsheng Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hunan Fangsheng Pharmaceutical Co's Market Cap falls into.


;
;

Hunan Fangsheng Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hunan Fangsheng Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥10.96*439.734
=¥4,819

Hunan Fangsheng Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥12.02*439.124
=¥5,278

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Fangsheng Pharmaceutical Co  (SHSE:603998) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hunan Fangsheng Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Fangsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
Executives
He Shi senior management
Xiao Han Qing senior management
Liu Xin He senior management
Chen Bo Director
Chen Ai Chun Director
Li Zhi Heng senior management
Zhou Wei En senior management
Zhang Qing Hua Director
Huang Min Director
Zhou Xiao Li senior management
Fang Jin Cheng Director
Fang Chuan Long Supervisors
Tan Yuan Ming Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines